Human hematopoietic lineage commitment

被引:25
作者
Payne, KJ [1 ]
Crooks, GM [1 ]
机构
[1] Childrens Hosp Los Angeles, Div Res Immunol Bone Marrow Transplantat, Los Angeles, CA 90027 USA
关键词
D O I
10.1034/j.1600-065X.2002.18705.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The ultimate goal of developmental immunology is to understand the normal processes that give rise to the immune system in order to diagnose and develop effective treatments for diseases that occur as a consequence of immune system defects. Central to achieving this goal is understanding the complex interplay between microenvironmental signals and transcription factors that direct human hematopoietic differentiation and lineage commitment. The ability to isolate highly purified populations of human hematopoietic cells at critical points in differentiation make it possible to answer very specific questions about the hematopoietic process and lineage restriction. This review describes the use of surface immunophenotypes to identify human hematopoietic cells at particular points in differentiation or with particular patterns of lineage restriction. Culture models are discussed in the context of the ability to detect, characterize and determine the lineage potential of human hematopoietic stem cells and progenitors. Variations in hematopoeises that correspond to ontogeny will be examined. Potential roles for the HOX and Ikaros proteins in human lineage commitment will be considered. Also included will be discussion of a number of factors that provide challenges to experimental design, to experimental interpretation, and to the development of a comprehensive model of human hematopoiesis.
引用
收藏
页码:48 / 64
页数:17
相关论文
共 119 条
[31]   Four-color flow cytometric investigation of terminal deoxynucleotidyl transferase-positive lymphoid precursors in pediatric bone marrow:: CD79a expression precedes CD19 in early B-cell ontogeny [J].
Dworzak, MN ;
Fritsch, G ;
Fröschl, G ;
Printz, D ;
Gadner, H .
BLOOD, 1998, 92 (09) :3203-3209
[32]  
FALKENBURG JHF, 1984, BLOOD, V63, P1125
[33]   HUMAN THYMOCYTE DEVELOPMENT IN MOUSE ORGAN-CULTURES [J].
FISHER, AG ;
LARSSON, L ;
GOFF, LK ;
RESTALL, DE ;
HAPPERFIELD, L ;
MERKENSCHLAGER, M .
INTERNATIONAL IMMUNOLOGY, 1990, 2 (06) :571-578
[34]   Proliferative involvement of ENX-1, a putative human Polycomb group gene, in haematopoietic cells [J].
Fukuyama, T ;
Otsuka, T ;
Shigematsu, H ;
Uchida, N ;
Arima, F ;
Ohno, Y ;
Iwasaki, H ;
Fukuda, T ;
Niho, Y .
BRITISH JOURNAL OF HAEMATOLOGY, 2000, 108 (04) :842-847
[35]  
Galy A, 2000, BLOOD, V95, P128
[36]   HUMAN T-CELLS, B-CELLS, NATURAL-KILLER, AND DENDRITIC CELLS ARISE FROM A COMMON BONE-MARROW PROGENITOR-CELL SUBSET [J].
GALY, A ;
TRAVIS, M ;
CEN, DZ ;
CHEN, B .
IMMUNITY, 1995, 3 (04) :459-473
[37]   DELINEATION OF T-PROGENITOR CELL-ACTIVITY WITHIN THE CD34(+) COMPARTMENT OF ADULT BONE-MARROW [J].
GALY, AHM ;
CEN, DZ ;
TRAVIS, M ;
CHEN, S ;
CHEN, BP .
BLOOD, 1995, 85 (10) :2770-2778
[38]   Human CD34+ cell preparations contain over 100-fold greater NOD/SCID mouse engrafting capacity than do CD34- cell preparations [J].
Gao, ZG ;
Fackler, MJ ;
Leung, W ;
Lumkul, R ;
Ramirez, M ;
Theobald, N ;
Malech, HL ;
Civin, CI .
EXPERIMENTAL HEMATOLOGY, 2001, 29 (07) :910-921
[39]   IKAROS, AN EARLY LYMPHOID-SPECIFIC TRANSCRIPTION FACTOR AND A PUTATIVE MEDIATOR FOR T-CELL COMMITMENT [J].
GEORGOPOULOS, K ;
MOORE, DD ;
DERFLER, B .
SCIENCE, 1992, 258 (5083) :808-812
[40]   KEY FUNCTIONAL-ROLE AND LINEAGE-SPECIFIC EXPRESSION OF SELECTED HOXB GENES IN PURIFIED HEMATOPOIETIC PROGENITOR DIFFERENTIATION [J].
GIAMPAOLO, A ;
STERPETTI, P ;
BULGARINI, D ;
SAMOGGIA, P ;
PELOSI, E ;
VALTIERI, M ;
PESCHLE, C .
BLOOD, 1994, 84 (11) :3637-3647